You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Sclerosis, Relapsing Remitting

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assess New Participant's Perspectives Beyond Clinical Efficacy

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
    • (no location specified)
    Nov 7, 2023

    Multiple Sclerosis, Relapsing-Remitting Trial in Elazig (Reiki)

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Reiki
    • Elazıg, Turkey
      Firat University
    Nov 8, 2023

    Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)

    Not yet recruiting
    • Relapsing Remitting Multiple Sclerosis
    • PIPE-307 Dose A
    • +2 more
    • (no location specified)
    Oct 9, 2023

    Multiple Sclerosis Trial in Montpellier (Magnetic Resonance Imaging, Blood withdrawal, Neuropsychological tests)

    Not yet recruiting
    • Multiple Sclerosis
    • Magnetic Resonance Imaging
    • +2 more
    • Montpellier, France
      Neurology Department, Hopital Gui de Chauliac
    Jul 18, 2023

    Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

    Not yet recruiting
    • Relapsing-remitting Multiple Sclerosis
    • CT-P53
    • +2 more
    • (no location specified)
    Jun 7, 2023

    Describe Switching FromFirst- or Second-line Disease Modifying

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
      • (no location specified)
      Dec 12, 2022

      Cardiometabolic Health in Multiple Sclerosis

      Recruiting
      • Multiple Sclerosis, Relapsing-Remitting
        • Diepenbeek, Limburg, Belgium
          Hasselt University
        Mar 1, 2023

        Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

        Not yet recruiting
        • Relapsing-remitting Multiple Sclerosis (RRMS)
          • (no location specified)
          Apr 11, 2023

          Multiple Sclerosis Trial in Genova (7-day Fasting-Mimicking Diet (7-DAY FMD))

          Active, not recruiting
          • Multiple Sclerosis
          • 7-day Fasting-Mimicking Diet (7-DAY FMD)
          • Genova, Italy
            Ospedale San Martino
          Sep 8, 2023

          Multiple Sclerosis, Relapsing-Remitting Trial in Porto Alegre (Cladribine 10 mg oral tablet)

          Active, not recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • Cladribine 10 mg oral tablet
          • Porto Alegre, RS, Brazil
            Pontifical Catholic University of Rio Grande do Sul
          Jun 5, 2023

          Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Chronic Progressive Trial in Cleveland (Cionic

          Recruiting
          • Multiple Sclerosis
          • +2 more
          • Cionic Neural Sleeve NS-100
          • Actigraph accelerometer
          • Cleveland, Ohio
            Cleveland State University
          Jul 25, 2023

          Multiple Sclerosis, Relapsing-Remitting, Fatigue Trial (TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY], Placebo)

          Withdrawn
          • Multiple Sclerosis, Relapsing-Remitting
          • Fatigue
          • TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY]
          • Placebo
          • Boston, Massachusetts
            Massachusetts General Hospital
          Nov 14, 2022

          Multiple Sclerosis, Relapsing-Remitting Trial in Munich, Mainz, Münster (Vivomixx®, Conjugated linoleic acid (CLA/Tonalin® FFA

          Not yet recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • Vivomixx®
          • +3 more
          • Munich, Bavaria, Germany
          • +2 more
          Jun 15, 2023

          Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Tokyo (OCH-NCNP1, Placebo)

          Active, not recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • Multiple Sclerosis, Secondary Progressive
          • Tokyo, Japan
            National Center of Neurology and Psychiatry
          Sep 28, 2022

          Multiple Sclerosis (MS) Patients

          Not yet recruiting
          • Multiple Sclerosis, Relapsing-Remitting
          • +2 more
            • (no location specified)
            Dec 15, 2022

            Multiple Sclerosis, Relapsing-Remitting Trial in Switzerland (serum Neurofilament Filament Light chain (sNfL) monitoring)

            Not yet recruiting
            • Multiple Sclerosis, Relapsing-Remitting
            • serum Neurofilament Filament Light chain (sNfL) monitoring
            • Basel, Basel Stadt, Switzerland
            • +7 more
            Oct 17, 2023

            Multiple Sclerosis, Relapsing-Remitting Trial in Richardson (Transcranial Direct Current Stimulation, Sham transcranial direct

            Not yet recruiting
            • Multiple Sclerosis, Relapsing-Remitting
            • Transcranial Direct Current Stimulation
            • Sham transcranial direct current stimulation
            • Richardson, Texas
              The University of Texas at Dallas
            Jul 14, 2023

            Multiple Sclerosis, Relapsing-Remitting Trial in La Jolla (Autologous hematopoietic stem cell transplantation,

            Recruiting
            • Multiple Sclerosis, Relapsing-Remitting
            • Autologous hematopoietic stem cell transplantation
            • +2 more
            • La Jolla, California
              Scripps Green Hospital
            Aug 16, 2022

            A Post-Authorization, Long-term Study of Ozanimod Real-world

            Active, not recruiting
            • Multiple Sclerosis, Relapsing-Remitting
              • Bethesda, Maryland
                Evidera
              Oct 31, 2022

              Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI

              Recruiting
              • Multiple Sclerosis, Relapsing-Remitting
              • West Orange, New Jersey
                Kessler Foundation
              Oct 12, 2022

              Bafiertam Treatment In Routine Clinical Practice

              Enrolling by invitation
              • Relapsing Remitting Multiple Sclerosis
              • Monomethyl Fumarate
              • West Hollywood, California
              • +1 more
              Aug 3, 2023

              Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Demyelinating Autoimmune Diseases, CNS Trial in Amsterdam

              Recruiting
              • Multiple Sclerosis
              • +5 more
              • Amsterdam, Netherlands
                Amsterdam UMC, location VUmc
              Apr 17, 2023

              Multiple Sclerosis, Relapsing-Remitting Trial in Paris (50 ml blodd sampling)

              Not yet recruiting
              • Multiple Sclerosis, Relapsing-Remitting
              • 50 ml blodd sampling
              • Paris, France
                Hôpital La Pitié - Salpêtrière
              Aug 16, 2022

              Elevated Factor VIII Related Labs asBiomarker for Incomplete

              Not yet recruiting
              • Multiple Sclerosis, Relapsing-Remitting
              • blood tests drawn days 1, 8, 22 and 90 of the study
              • (no location specified)
              Jun 22, 2023

              Multiple Sclerosis, Relapsing-Remitting, Healthy Controls Trial in Garches (Neuropsychological tests and psychological

              Recruiting
              • Multiple Sclerosis, Relapsing-Remitting
              • Healthy Controls
              • Neuropsychological tests and psychological questionnaires
              • Garches, Hauts De Seine, France
                Hopital Raymond Poincaré Garches
              Dec 5, 2022